- Home
- QVCGB vs APLS Comparison
QVCGB vs APLS Comparison
Compare QVCGB & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGB
- APLS
- Stock Information
- Founded
- QVCGB 1991
- APLS 2009
- Country
- QVCGB United States
- APLS United States
- Employees
- QVCGB N/A
- APLS N/A
- Industry
- QVCGB
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGB
- APLS Health Care
- Exchange
- QVCGB NYSE
- APLS Nasdaq
- Market Cap
- QVCGB 2.3B
- APLS 2.3B
- IPO Year
- QVCGB N/A
- APLS 2017
- Fundamental
- Price
- QVCGB $6.24
- APLS $17.30
- Analyst Decision
- QVCGB
- APLS Buy
- Analyst Count
- QVCGB 0
- APLS 19
- Target Price
- QVCGB N/A
- APLS $39.06
- AVG Volume (30 Days)
- QVCGB 26.3K
- APLS 2.7M
- Earning Date
- QVCGB 05-07-2025
- APLS 05-07-2025
- Dividend Yield
- QVCGB N/A
- APLS N/A
- EPS Growth
- QVCGB N/A
- APLS N/A
- EPS
- QVCGB N/A
- APLS N/A
- Revenue
- QVCGB $9,800,000,000.00
- APLS $775,839,000.00
- Revenue This Year
- QVCGB $2.89
- APLS $12.25
- Revenue Next Year
- QVCGB $0.45
- APLS $21.08
- P/E Ratio
- QVCGB N/A
- APLS N/A
- Revenue Growth
- QVCGB N/A
- APLS 48.04
- 52 Week Low
- QVCGB $2.00
- APLS $16.65
- 52 Week High
- QVCGB $18.74
- APLS $43.99
- Technical
- Relative Strength Index (RSI)
- QVCGB N/A
- APLS 34.14
- Support Level
- QVCGB N/A
- APLS $16.65
- Resistance Level
- QVCGB N/A
- APLS $20.75
- Average True Range (ATR)
- QVCGB 0.00
- APLS 1.09
- MACD
- QVCGB 0.00
- APLS 0.14
- Stochastic Oscillator
- QVCGB 0.00
- APLS 15.85
About QVCGB QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.